195 related articles for article (PubMed ID: 37572121)
1. Glial cell-derived soluble factors increase the metastatic potential of pancreatic adenocarcinoma cells and induce epithelial-to-mesenchymal transition.
García-Reyes B; Kuzmanov I; Schneider R; Schneiker B; Efferz P; Kalff JC; Wehner S
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14315-14327. PubMed ID: 37572121
[TBL] [Abstract][Full Text] [Related]
2. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
3. Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells.
Fujii-Nishimura Y; Yamazaki K; Masugi Y; Douguchi J; Kurebayashi Y; Kubota N; Ojima H; Kitago M; Shinoda M; Hashiguchi A; Sakamoto M
Pathol Int; 2018 Apr; 68(4):214-223. PubMed ID: 29457853
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition.
Xiong C; Zhu Y; Xue M; Jiang Y; Zhong Y; Jiang L; Shi M; Chen H
Aging (Albany NY); 2021 Jan; 13(3):3386-3404. PubMed ID: 33428605
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
[TBL] [Abstract][Full Text] [Related]
6. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
7. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.
Mizuuchi Y; Aishima S; Ohuchida K; Shindo K; Fujino M; Hattori M; Miyazaki T; Mizumoto K; Tanaka M; Oda Y
Lab Invest; 2015 Feb; 95(2):193-206. PubMed ID: 25418581
[TBL] [Abstract][Full Text] [Related]
8. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression.
Carrasco-Garcia E; Lopez L; Moncho-Amor V; Carazo F; Aldaz P; Collado M; Bell D; Gaafar A; Karamitopoulou E; Tzankov A; Hidalgo M; Rubio Á; Serrano M; Lawrie CH; Lovell-Badge R; Matheu A
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205666
[TBL] [Abstract][Full Text] [Related]
9. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.
Nishino H; Takano S; Yoshitomi H; Suzuki K; Kagawa S; Shimazaki R; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
Cancer Med; 2017 Nov; 6(11):2686-2696. PubMed ID: 28960866
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.
Li Z; Zhao X; Zhou Y; Liu Y; Zhou Q; Ye H; Wang Y; Zeng J; Song Y; Gao W; Zheng S; Zhuang B; Chen H; Li W; Li H; Li H; Fu Z; Chen R
J Transl Med; 2015 Mar; 13():84. PubMed ID: 25889214
[TBL] [Abstract][Full Text] [Related]
11. The neurotrophic factor artemin promotes pancreatic cancer invasion.
Ceyhan GO; Giese NA; Erkan M; Kerscher AG; Wente MN; Giese T; Büchler MW; Friess H
Ann Surg; 2006 Aug; 244(2):274-81. PubMed ID: 16858191
[TBL] [Abstract][Full Text] [Related]
12. CCR4
Sharma V; Sachdeva N; Gupta V; Nada R; Jacob J; Sahni D; Aggarwal A
Immunobiology; 2022 May; 227(3):152210. PubMed ID: 35358941
[TBL] [Abstract][Full Text] [Related]
13. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
15. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity.
Schmidtlein PM; Volz C; Braun R; Thürling I; Lapshyna O; Wellner UF; Konukiewitz B; Lehnert H; Marquardt JU; Ungefroren H
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572891
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
[TBL] [Abstract][Full Text] [Related]
18. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion.
Tian Z; Ou G; Su M; Li R; Pan L; Lin X; Zou J; Chen S; Li Y; Huang K; Chen Y
Cancer Lett; 2022 Oct; 546():215863. PubMed ID: 35961511
[TBL] [Abstract][Full Text] [Related]
19. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
20. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]